NFE2L2 and breast cancer: To gain insight on the antioxidant role of NRF2 in breast cancer cells treated with NS1643, we measured ROS levels in cells in which NRF2 was suppressed by siRNA (siRNA-NRF2; Supplementary Figure 4B) and then treated with NS1643 (Fig. 6B).